DNA Initiates Development of Hemp Based Wellness Shots

Fort Lauderdale , April 20, 2016 -- DNA Initiates Development of Hemp Based Wellness Shots

DNA Brands Inc.(OTC Pink: DNAX) is pleased to announce that in addition to the planned relaunched of the company’s award winning line of DNA Energy drinks, that the company’s new joint venture with Accel Brands, Inc (OTC Pink:ACLP) , Accel-DNA, Inc., led by Mr,. Janon Costley,  has initiated product development discussions with one of the largest High Grade Hemp/CBD producers (producer)  in the country to develop a line of DNA branded wellness shots and potentially other branded products. The all natural, key ingredient, Cannabidiol, is extracted from the industrial hemp plant. This process along with other key factors enable the products to be legal in all 50 states and creates no legal or regulatory hurdles surrounding Cannabis. This privately held company has been compounding for over 20 years and has the technical and clinical experience both physicians and patients have come to trust as a provider of alternatives to chemical based treatment options. Currently their over the counter products are being sold in over 2500+ retail locations across the United States. The parties intend to use the “producers” patent pending pharmaceutical-grade Cannabidiol products, to develop a line of DNA branded all natural, plant based wellness shots formulated using the pure 99% CBD (Cannabidiol) concentrate.

The plan is to have shots that will come as a Tri-Pack and will have 3 formula’s:

1. Sleep
2. Calming
3. Energy

“ It is a natural fit to align a brand such as DNA  with a market leader in the growing CBD space that can help to position the new DNA product line for instant penetration into a proven channel of distribution”, stated Mr. Costley.  “The goal of this relationship is to hopefully create a quality line of DNA branded CBD infused products that can be used as effective forms of alternative treatment understanding that many people experience the occasional need to manage a variety of quality of life medical issues. The initial plan is to develop a sample run of several products that will be soft launched into key points of distribution for market feedback to determine next steps” Stated, DNA CEO, Adrian Mckenzie. Please continue to follow the company for more updates and news regarding this opportunity.

Adrian McKenzie

[email protected]

(561) 654-5722